Avricore Health (AVCRF) Liabilities and Shareholders Equity (2013 - 2025)

Avricore Health (AVCRF) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $403809.2 in Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $403809.2, down 75.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.1 million (down 48.25% YoY), and the FY2025 annual result was $403040.6, down 75.99% from the prior year.
• Liabilities and Shareholders Equity declined to $403809.2 in Q4 2025 per AVCRF's latest filing, from $965908.6 in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.2 million in Q3 2024 and troughed at $403809.2 in Q4 2025.
• A 5-year average of $1.7 million and a median of $1.8 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2021 and 2025: Liabilities and Shareholders Equity surged 649.04% in 2021, then slumped 75.46% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.8 million in 2021, then advanced by 4.57% to $1.9 million in 2022, then fell by 1.49% to $1.9 million in 2023, then declined by 11.75% to $1.6 million in 2024, then tumbled by 75.46% to $403809.2 in 2025.
• Business Quant data shows AVCRF's Liabilities and Shareholders Equity at $403809.2 in Q4 2025, $965908.6 in Q3 2025, and $1.2 million in Q2 2025.